Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 26 | 2024 | 101 | 4.740 |
Why?
|
| Republic of Korea | 65 | 2024 | 107 | 3.030 |
Why?
|
| Risk Factors | 76 | 2024 | 3562 | 2.240 |
Why?
|
| Incidence | 54 | 2024 | 922 | 2.220 |
Why?
|
| Stroke | 14 | 2023 | 286 | 1.930 |
Why?
|
| Drosophila Proteins | 4 | 2024 | 171 | 1.730 |
Why?
|
| Tuberculosis | 8 | 2024 | 63 | 1.660 |
Why?
|
| Drosophila melanogaster | 4 | 2024 | 180 | 1.430 |
Why?
|
| Cohort Studies | 37 | 2024 | 1492 | 1.420 |
Why?
|
| Bronchiectasis | 6 | 2024 | 10 | 1.320 |
Why?
|
| Aged | 58 | 2024 | 6741 | 1.310 |
Why?
|
| Middle Aged | 73 | 2024 | 10129 | 1.270 |
Why?
|
| Hypertension | 7 | 2024 | 796 | 1.210 |
Why?
|
| Mushroom Bodies | 2 | 2020 | 3 | 1.180 |
Why?
|
| Diabetes Mellitus | 5 | 2024 | 485 | 1.160 |
Why?
|
| Proportional Hazards Models | 22 | 2024 | 441 | 1.120 |
Why?
|
| Male | 80 | 2024 | 20025 | 1.070 |
Why?
|
| Humans | 111 | 2024 | 37093 | 1.070 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2023 | 169 | 1.070 |
Why?
|
| Female | 81 | 2024 | 20969 | 1.060 |
Why?
|
| Kidney Failure, Chronic | 3 | 2023 | 233 | 1.050 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2023 | 21 | 1.010 |
Why?
|
| Dopamine | 2 | 2024 | 245 | 1.010 |
Why?
|
| Adult | 61 | 2024 | 11712 | 1.000 |
Why?
|
| Ethanol | 2 | 2024 | 192 | 0.990 |
Why?
|
| Keratosis, Actinic | 2 | 2021 | 4 | 0.980 |
Why?
|
| Receptors, Dopamine | 2 | 2024 | 25 | 0.960 |
Why?
|
| Myocardial Infarction | 8 | 2023 | 225 | 0.940 |
Why?
|
| Dementia | 5 | 2023 | 131 | 0.910 |
Why?
|
| Psoriasis | 5 | 2021 | 17 | 0.890 |
Why?
|
| Dementia, Vascular | 5 | 2023 | 36 | 0.890 |
Why?
|
| Databases, Factual | 14 | 2022 | 291 | 0.880 |
Why?
|
| Acetylcholine | 1 | 2022 | 73 | 0.860 |
Why?
|
| Nutrition Surveys | 10 | 2020 | 242 | 0.850 |
Why?
|
| Lung Neoplasms | 5 | 2023 | 358 | 0.820 |
Why?
|
| Synaptic Transmission | 1 | 2022 | 146 | 0.810 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2024 | 149 | 0.770 |
Why?
|
| Neurons | 3 | 2020 | 1175 | 0.740 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2020 | 5 | 0.730 |
Why?
|
| Smoking | 11 | 2022 | 940 | 0.720 |
Why?
|
| Association Learning | 1 | 2020 | 30 | 0.720 |
Why?
|
| Smell | 1 | 2020 | 36 | 0.710 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2024 | 43 | 0.680 |
Why?
|
| Sleep | 2 | 2017 | 152 | 0.630 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 643 | 0.630 |
Why?
|
| Anticoagulants | 5 | 2023 | 102 | 0.590 |
Why?
|
| Population Surveillance | 6 | 2021 | 238 | 0.590 |
Why?
|
| Peptic Ulcer | 1 | 2016 | 9 | 0.580 |
Why?
|
| Retrospective Studies | 17 | 2024 | 2026 | 0.560 |
Why?
|
| Prevalence | 17 | 2024 | 1455 | 0.560 |
Why?
|
| Anemia | 4 | 2021 | 45 | 0.550 |
Why?
|
| Laryngeal Neoplasms | 3 | 2021 | 11 | 0.550 |
Why?
|
| Diabetic Retinopathy | 4 | 2018 | 68 | 0.550 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2022 | 62 | 0.540 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2021 | 52 | 0.540 |
Why?
|
| Alzheimer Disease | 5 | 2023 | 905 | 0.530 |
Why?
|
| Hemoglobins | 3 | 2021 | 107 | 0.520 |
Why?
|
| Behavior, Animal | 3 | 2024 | 314 | 0.510 |
Why?
|
| Heart Failure | 4 | 2022 | 235 | 0.500 |
Why?
|
| Prediabetic State | 3 | 2022 | 53 | 0.500 |
Why?
|
| Oviposition | 1 | 2014 | 13 | 0.490 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 664 | 0.490 |
Why?
|
| Signal Transduction | 3 | 2024 | 1908 | 0.480 |
Why?
|
| Dermatitis, Atopic | 2 | 2024 | 12 | 0.460 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 86 | 0.460 |
Why?
|
| Appetitive Behavior | 1 | 2013 | 11 | 0.440 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2013 | 21 | 0.440 |
Why?
|
| Aged, 80 and over | 15 | 2021 | 2379 | 0.430 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 127 | 0.430 |
Why?
|
| Alcohol Drinking | 8 | 2024 | 519 | 0.430 |
Why?
|
| Tachycardia, Ventricular | 2 | 2023 | 12 | 0.420 |
Why?
|
| Case-Control Studies | 8 | 2024 | 1130 | 0.420 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 61 | 0.420 |
Why?
|
| Neoplasms | 2 | 2021 | 1103 | 0.410 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2023 | 8 | 0.390 |
Why?
|
| Ventricular Premature Complexes | 2 | 2021 | 10 | 0.390 |
Why?
|
| Albuminuria | 3 | 2017 | 76 | 0.390 |
Why?
|
| Young Adult | 17 | 2024 | 4268 | 0.380 |
Why?
|
| Disease Susceptibility | 5 | 2021 | 97 | 0.380 |
Why?
|
| Parkinson Disease | 2 | 2024 | 178 | 0.380 |
Why?
|
| Risk Assessment | 8 | 2024 | 753 | 0.370 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 974 | 0.370 |
Why?
|
| National Health Programs | 5 | 2021 | 17 | 0.360 |
Why?
|
| Brain Infarction | 2 | 2020 | 20 | 0.350 |
Why?
|
| Sexual Behavior, Animal | 1 | 2010 | 53 | 0.350 |
Why?
|
| Comorbidity | 6 | 2021 | 623 | 0.350 |
Why?
|
| Body Height | 2 | 2021 | 53 | 0.340 |
Why?
|
| Health Surveys | 3 | 2020 | 373 | 0.340 |
Why?
|
| Cause of Death | 5 | 2022 | 156 | 0.330 |
Why?
|
| Life Style | 2 | 2021 | 308 | 0.330 |
Why?
|
| Hearing Loss | 2 | 2020 | 15 | 0.320 |
Why?
|
| Brain Ischemia | 2 | 2022 | 184 | 0.320 |
Why?
|
| Animals | 7 | 2024 | 15081 | 0.310 |
Why?
|
| Obesity | 8 | 2023 | 1067 | 0.310 |
Why?
|
| Drosophila | 2 | 2022 | 144 | 0.300 |
Why?
|
| Thinness | 3 | 2022 | 29 | 0.300 |
Why?
|
| Blood Glucose | 4 | 2023 | 353 | 0.300 |
Why?
|
| Body Mass Index | 6 | 2023 | 854 | 0.290 |
Why?
|
| Aging | 2 | 2022 | 664 | 0.290 |
Why?
|
| Stomach Neoplasms | 2 | 2019 | 195 | 0.280 |
Why?
|
| Prognosis | 7 | 2023 | 739 | 0.270 |
Why?
|
| Korea | 4 | 2019 | 43 | 0.270 |
Why?
|
| Ventricular Fibrillation | 2 | 2024 | 9 | 0.260 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 441 | 0.250 |
Why?
|
| Depression | 2 | 2021 | 712 | 0.250 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 25 | 0.250 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 27 | 0.240 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2024 | 50 | 0.240 |
Why?
|
| Arteritis | 1 | 2024 | 1 | 0.240 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2024 | 1 | 0.240 |
Why?
|
| Longitudinal Studies | 6 | 2023 | 885 | 0.240 |
Why?
|
| Waist Circumference | 3 | 2021 | 89 | 0.240 |
Why?
|
| Central Nervous System Depressants | 1 | 2024 | 37 | 0.240 |
Why?
|
| Blood Pressure | 3 | 2024 | 646 | 0.240 |
Why?
|
| Heart Arrest | 1 | 2024 | 35 | 0.230 |
Why?
|
| Multivariate Analysis | 7 | 2021 | 583 | 0.230 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2024 | 40 | 0.230 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 11 | 0.230 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2023 | 18 | 0.230 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 11 | 0.230 |
Why?
|
| Registries | 3 | 2021 | 335 | 0.230 |
Why?
|
| Hip Fractures | 1 | 2023 | 23 | 0.230 |
Why?
|
| Locomotion | 1 | 2024 | 97 | 0.230 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2024 | 21 | 0.230 |
Why?
|
| Treatment Outcome | 6 | 2024 | 1369 | 0.230 |
Why?
|
| Administration, Oral | 5 | 2023 | 224 | 0.230 |
Why?
|
| Wet Macular Degeneration | 1 | 2023 | 3 | 0.220 |
Why?
|
| Fractures, Bone | 1 | 2023 | 53 | 0.220 |
Why?
|
| Social Behavior | 1 | 2024 | 131 | 0.220 |
Why?
|
| Causality | 1 | 2022 | 44 | 0.220 |
Why?
|
| Pancreatitis | 1 | 2022 | 17 | 0.220 |
Why?
|
| Behcet Syndrome | 1 | 2022 | 2 | 0.220 |
Why?
|
| Social Environment | 1 | 2024 | 207 | 0.210 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 75 | 0.210 |
Why?
|
| Weight Gain | 2 | 2020 | 136 | 0.210 |
Why?
|
| Overweight | 3 | 2022 | 247 | 0.210 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2022 | 17 | 0.210 |
Why?
|
| Nasal Obstruction | 1 | 2021 | 3 | 0.210 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 139 | 0.210 |
Why?
|
| Nasal Septum | 1 | 2021 | 5 | 0.200 |
Why?
|
| Migraine Disorders | 1 | 2021 | 7 | 0.200 |
Why?
|
| Lung Diseases | 1 | 2022 | 61 | 0.200 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2021 | 3 | 0.200 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 9 | 0.200 |
Why?
|
| Uvula | 1 | 2021 | 1 | 0.200 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 12 | 0.200 |
Why?
|
| Palate | 1 | 2021 | 7 | 0.200 |
Why?
|
| Pharynx | 1 | 2021 | 16 | 0.200 |
Why?
|
| Motor Activity | 1 | 2024 | 418 | 0.190 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 186 | 0.190 |
Why?
|
| Diabetes Complications | 1 | 2021 | 90 | 0.190 |
Why?
|
| Appendectomy | 1 | 2020 | 16 | 0.190 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 16 | 0.190 |
Why?
|
| Vitiligo | 1 | 2020 | 3 | 0.180 |
Why?
|
| Vision, Low | 1 | 2020 | 13 | 0.180 |
Why?
|
| Octopamine | 1 | 2020 | 8 | 0.180 |
Why?
|
| Body Weight | 2 | 2021 | 434 | 0.180 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 60 | 0.180 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 284 | 0.180 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 78 | 0.180 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 336 | 0.180 |
Why?
|
| Cholesterol | 1 | 2021 | 205 | 0.180 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 99 | 0.180 |
Why?
|
| Postmenopause | 2 | 2022 | 128 | 0.180 |
Why?
|
| Hyperuricemia | 1 | 2019 | 10 | 0.180 |
Why?
|
| Mycobacterium Infections | 1 | 2019 | 16 | 0.180 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 8 | 0.170 |
Why?
|
| Mouth Neoplasms | 1 | 2020 | 71 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 111 | 0.170 |
Why?
|
| Postoperative Complications | 1 | 2020 | 210 | 0.170 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 142 | 0.170 |
Why?
|
| Sex Characteristics | 1 | 2021 | 230 | 0.170 |
Why?
|
| Cognition | 1 | 2022 | 398 | 0.170 |
Why?
|
| Asthma | 1 | 2023 | 380 | 0.170 |
Why?
|
| Disabled Persons | 1 | 2019 | 65 | 0.160 |
Why?
|
| Thiazoles | 1 | 2019 | 74 | 0.160 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 37 | 0.160 |
Why?
|
| Infant | 4 | 2024 | 1046 | 0.160 |
Why?
|
| Pyridines | 1 | 2019 | 116 | 0.160 |
Why?
|
| Vitamin K | 1 | 2017 | 6 | 0.160 |
Why?
|
| Dysphonia | 1 | 2017 | 4 | 0.150 |
Why?
|
| Thromboembolism | 1 | 2017 | 13 | 0.150 |
Why?
|
| Fibrosis | 3 | 2023 | 159 | 0.150 |
Why?
|
| Proteinuria | 1 | 2017 | 50 | 0.150 |
Why?
|
| Logistic Models | 5 | 2019 | 923 | 0.150 |
Why?
|
| Hemorrhage | 3 | 2023 | 45 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 63 | 0.150 |
Why?
|
| Alcoholism | 1 | 2020 | 240 | 0.150 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 42 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 52 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2017 | 43 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 159 | 0.140 |
Why?
|
| Exercise | 4 | 2023 | 613 | 0.140 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 9 | 0.140 |
Why?
|
| Risk | 3 | 2021 | 267 | 0.130 |
Why?
|
| Drug Therapy, Combination | 3 | 2022 | 227 | 0.130 |
Why?
|
| Laryngitis | 1 | 2015 | 2 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 15 | 0.130 |
Why?
|
| Blepharoptosis | 1 | 2015 | 3 | 0.130 |
Why?
|
| Tinnitus | 1 | 2015 | 3 | 0.130 |
Why?
|
| Health | 1 | 2015 | 30 | 0.130 |
Why?
|
| Particulate Matter | 1 | 2015 | 51 | 0.130 |
Why?
|
| Oviducts | 1 | 2014 | 13 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 494 | 0.120 |
Why?
|
| Anxiety | 1 | 2021 | 754 | 0.120 |
Why?
|
| Infertility, Female | 1 | 2014 | 24 | 0.120 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 610 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 73 | 0.120 |
Why?
|
| Smoking Cessation | 1 | 2020 | 517 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2015 | 184 | 0.110 |
Why?
|
| Vitamin D | 1 | 2014 | 196 | 0.100 |
Why?
|
| Survivors | 2 | 2023 | 136 | 0.100 |
Why?
|
| Sex Factors | 3 | 2021 | 898 | 0.100 |
Why?
|
| Warfarin | 2 | 2023 | 64 | 0.100 |
Why?
|
| Quality of Life | 1 | 2015 | 481 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 893 | 0.090 |
Why?
|
| Sex Attractants | 1 | 2010 | 4 | 0.090 |
Why?
|
| Genes, Insect | 1 | 2010 | 26 | 0.090 |
Why?
|
| Vibration | 1 | 2010 | 23 | 0.090 |
Why?
|
| Touch | 1 | 2010 | 19 | 0.090 |
Why?
|
| Vocalization, Animal | 1 | 2010 | 22 | 0.090 |
Why?
|
| Child | 3 | 2024 | 3131 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2024 | 894 | 0.090 |
Why?
|
| Adolescent | 4 | 2024 | 5363 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 935 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1502 | 0.080 |
Why?
|
| Creatinine | 2 | 2019 | 103 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2024 | 1418 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 360 | 0.070 |
Why?
|
| Age Factors | 2 | 2021 | 1033 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 534 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 1095 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 2 | 2015 | 146 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2010 | 681 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 2721 | 0.060 |
Why?
|
| Taiwan | 1 | 2024 | 14 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2024 | 53 | 0.060 |
Why?
|
| Rifampin | 1 | 2023 | 4 | 0.060 |
Why?
|
| Antitubercular Agents | 1 | 2023 | 28 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2023 | 85 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 147 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 38 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 97 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2021 | 11 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 1 | 0.050 |
Why?
|
| Oral Surgical Procedures | 1 | 2021 | 4 | 0.050 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2021 | 3 | 0.050 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2021 | 17 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2021 | 18 | 0.050 |
Why?
|
| Estrogens | 1 | 2022 | 202 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 113 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2021 | 156 | 0.050 |
Why?
|
| Hospitalization | 1 | 2024 | 388 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 26 | 0.050 |
Why?
|
| Survival Rate | 1 | 2021 | 311 | 0.040 |
Why?
|
| Gastroscopy | 1 | 2019 | 7 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2020 | 97 | 0.040 |
Why?
|
| Chest Pain | 1 | 2020 | 37 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2018 | 17 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 143 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2019 | 23 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 75 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2019 | 35 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2018 | 29 | 0.040 |
Why?
|
| Weight Loss | 1 | 2019 | 131 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 399 | 0.040 |
Why?
|
| Mortality | 1 | 2018 | 145 | 0.040 |
Why?
|
| Fasting | 1 | 2017 | 54 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 628 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 1067 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 400 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 325 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 455 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1549 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 149 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 225 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1371 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 30 | 0.030 |
Why?
|
| Particle Size | 1 | 2015 | 215 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 194 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 166 | 0.030 |
Why?
|
| Lipids | 1 | 2015 | 235 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 1378 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2015 | 484 | 0.030 |
Why?
|